COMP <GO>
MMM vs ABBV // 10Y YIELD & FRED MACRO BETA
3M Company (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MMM 5
— ABBV 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: ABBV
LAST: $174.34 (-1.70%) • MKT CAP: $91.65B
macro-sensitivity
0.91
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
macro-sensitivity
1.15
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMM VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMM | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.90% | 70.20% | -30.30 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 32.90% | 29.00% | +3.90 | MMM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.1x | 33.3x | -15.20 | MMM | /valuation <GO> |
| Free Cash Flow Yield | 1.52% | 3.47% | -1.95 | ABBV | /fcf-yield <GO> |
| Operating Margin | 18.60% | 24.60% | -6.00 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 13.00% | 6.90% | +6.10 | MMM | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 8.60% | -7.10 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.70% | 2.27% | -0.57 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.37 | 5.33 | -0.96 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.40% | -0.80 | MMM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 72.8 | -14.26 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.91 | 1.15 | -0.24 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.2x | 113.1x | -86.90 | MMM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $91.65B | $513.86B | -$422.21B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMM REV | ABBV REV | MMM GROSS % | ABBV GROSS % | MMM FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.95B | $61.16B | 39.9% | 70.2% | $1.40B | $17.82B |
| FY 2024 | $24.57B | $56.33B | 41.2% | 70.0% | $638.0M | $17.83B |
| FY 2023 | $24.61B | $54.32B | 44.0% | 44.0% | $5.57B | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMM // BETA 0.91
ABBV // BETA 1.15